Golden State Wealth Management LLC purchased a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 1,545 shares of the medical equipment provider’s stock, valued at approximately $806,000.
Other institutional investors also recently modified their holdings of the company. SMART Wealth LLC raised its holdings in Intuitive Surgical by 13.4% during the 4th quarter. SMART Wealth LLC now owns 669 shares of the medical equipment provider’s stock valued at $349,000 after acquiring an additional 79 shares during the period. Global X Japan Co. Ltd. grew its position in shares of Intuitive Surgical by 9.8% in the fourth quarter. Global X Japan Co. Ltd. now owns 46,289 shares of the medical equipment provider’s stock valued at $24,161,000 after purchasing an additional 4,140 shares in the last quarter. Beese Fulmer Investment Management Inc. raised its stake in shares of Intuitive Surgical by 4.3% during the 4th quarter. Beese Fulmer Investment Management Inc. now owns 1,598 shares of the medical equipment provider’s stock valued at $834,000 after purchasing an additional 66 shares during the period. Livforsakringsbolaget Skandia Omsesidigt boosted its stake in Intuitive Surgical by 175.2% in the 4th quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 8,043 shares of the medical equipment provider’s stock worth $4,198,000 after purchasing an additional 5,120 shares during the period. Finally, Sumitomo Mitsui Trust Group Inc. grew its holdings in Intuitive Surgical by 5.0% during the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,523,863 shares of the medical equipment provider’s stock valued at $795,396,000 after buying an additional 73,225 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of equities analysts have recently commented on ISRG shares. Robert W. Baird raised their price objective on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. Raymond James raised their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a report on Friday, January 24th. Citigroup upped their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a report on Friday, January 24th. Barclays lifted their price objective on Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Finally, Evercore ISI upped their target price on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. One research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.
Insider Activity
In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Jamie Samath sold 94 shares of the business’s stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the transaction, the chief financial officer now directly owns 2,630 shares in the company, valued at $1,502,019.30. This trade represents a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 5,940 shares of company stock valued at $3,333,485. Insiders own 0.80% of the company’s stock.
Intuitive Surgical Stock Down 0.4 %
Intuitive Surgical stock opened at $588.50 on Friday. The firm has a fifty day simple moving average of $553.03 and a two-hundred day simple moving average of $512.59. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00. The company has a market capitalization of $209.61 billion, a PE ratio of 91.81, a P/E/G ratio of 5.51 and a beta of 1.39.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading
- Five stocks we like better than Intuitive Surgical
- What is a Low P/E Ratio and What Does it Tell Investors?
- Uber’s Business, Cash Flow, and AI are Why it Will Set a New High
- Short Selling – The Pros and Cons
- Weak Guidance from Bristol-Myers Could Be Creating an Opportunity
- Pros And Cons Of Monthly Dividend Stocks
- These are the 3 Stocks Most Likely to Split in 2025
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.